Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,008 public trials 712 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

NCT02305381

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Lomita, California, United States
View all 99 locations
View Trial Details
Completed

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

NCT02582242

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
Locations
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Oran, Algeria
  • Novo Nordisk Investigational Site Hefei, Anhui, China
View all 50 locations
View Trial Details
Completed

A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.

NCT02533453

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Busan, South Korea
  • Research Site Daegu, South Korea
  • Research Site Daejeon, South Korea
  • Research Site Gwangju, South Korea
View all 15 locations
View Trial Details

Related conditions